Braskem S.A. (BAK): A Bull Case Theory

3 weeks ago 13

We came crossed a bullish thesis connected Braskem S.A. connected Penny connected the Dollar’s Substack. In this article, we volition summarize the bulls’ thesis connected BAK. Braskem S.A.'s stock was trading astatine $3.7300 arsenic of February 12th. BAK’s trailing and guardant P/E were 8.44 and 9.78 respectively according to Yahoo Finance.

Fluence Energy (FLNC) Jumps 21% Alongside Peers arsenic  JPMorgan Bares Trillion-Dollar Investment

Fluence Energy (FLNC) Jumps 21% Alongside Peers arsenic JPMorgan Bares Trillion-Dollar Investment

Photo by RawFilm connected Unsplash

Braskem S.A., a CCC-rated Brazilian petrochemical giant, trades astatine $2.86 per ADR, giving it a marketplace headdress of $1.15 cardinal and an endeavor worth of $8.15 billion, efficaciously pricing the banal arsenic a endurance option. The institution operates 4 integrated complexes successful Brazil, a state-of-the-art ethane cracker successful Mexico, 5 plants successful the U.S., and 2 successful Germany, with replacement outgo exceeding $20 billion, meaning investors tin get world-scale, irreplaceable infrastructure astatine astir 35% of its depreciated value.

Braskem’s Brazilian operations bask a earthy moat, arsenic tariffs and freight costs support home pricing, portion its Mexican Braskem Idesa joint task has precocious flooded chronic feedstock proviso issues, present moving astatine afloat commercialized capableness aft constructing an ethane import terminal. Two longstanding overhangs person suppressed the stock: the Alagoas brackish mining disaster, which has mostly been resolved with remaining provisions declining, and governance paralysis caused by controlling shareholder Novonor’s troubled past and Petrobras’ veto and tag-along rights.

In December 2025, IG4 Capital agreed to acquire Novonor’s 38.3% involvement via distressed indebtedness conversion, perchance removing the distressed-seller overhang and aligning absorption incentives, though Petrobras’ support remains critical. Cyclical headwinds person depressed earnings, with Q3 2025 recurring EBITDA astatine R$818 cardinal and nett nonaccomplishment of R$174 million, but the equilibrium expanse provides runway until a assemblage recovery.

Mid-cycle projections for 2027, incorporating Mexico’s ramp-up, REIQ taxation credits, and dispersed recovery, connote endeavor worth of R$16.8 billion, equating to 700–800% imaginable upside from the existent marketplace price. While risks see recession, governmental expropriation, Alagoas process risk, oregon IG4 woody failure, Braskem represents a uncommon distressed equity accidental with utmost asymmetry, trading good beneath replacement outgo yet poised for important rerating if governance and cyclicality normalize.

Previously, we covered a bullish thesis connected Eastman Chemical Company (EMN) by Necessary-Damage5658 successful November 2024, which highlighted the company’s beardown positioning amid export power changes and regulatory-compliant operations driving resilient earnings. EMN’s banal terms has depreciated by astir 21.04% since our coverage. Penny connected the Dollar shares a akin but emphasizes Braskem’s distressed-equity opportunity, with replacement-cost arbitrage and governance solution offering important upside.

Read Entire Article